In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Aldara, Imiquimod Drug Master File in Korea (Aldara, Imiquimod KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aldara, Imiquimod. The MFDS reviews the Aldara, Imiquimod KDMF as part of the drug registration process and uses the information provided in the Aldara, Imiquimod KDMF to evaluate the safety and efficacy of the drug.
After submitting a Aldara, Imiquimod KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aldara, Imiquimod API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Aldara, Imiquimod suppliers with KDMF on PharmaCompass.